These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36878177)

  • 1. CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study.
    Müller-Vahl KR; Pisarenko A; Szejko N; Haas M; Fremer C; Jakubovski E; Musil R; Münchau A; Neuner I; Huys D; van Elst LT; Schröder C; Ringlstetter R; Koch A; Jenz EB; Großhennig A
    Psychiatry Res; 2023 May; 323():115135. PubMed ID: 36878177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders.
    Jakubovski E; Pisarenko A; Fremer C; Haas M; May M; Schumacher C; Schindler C; Häckl S; Aguirre Davila L; Koch A; Brunnauer A; Cimpianu CL; Lutz B; Bindila L; Müller-Vahl K
    Front Psychiatry; 2020; 11():575826. PubMed ID: 33324255
    [No Abstract]   [Full Text] [Related]  

  • 3. The Effect of Nabiximols on Driving Ability in Adults with Chronic Tic Disorders: Results of a Substudy Analysis of the Double-Blind, Randomized, Placebo-Controlled CANNA-TICS Trial.
    Müller-Vahl KR; Pisarenko A; Ringlstetter R; Cimpianu CL; Fremer C; Weidinger E; Jenz EB; Musil R; Brunnauer A; Großhennig A
    Cannabis Cannabinoid Res; 2024 Jan; ():. PubMed ID: 38265476
    [No Abstract]   [Full Text] [Related]  

  • 4. Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome.
    Szejko N; Saramak K; Lombroso A; Müller-Vahl K
    Neurol Neurochir Pol; 2022; 56(1):28-38. PubMed ID: 34708399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
    Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tourette syndrome in a longitudinal perspective. Clinical course of tics and comorbidities, coexisting psychopathologies, phenotypes and predictors.
    Groth C
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, sham-controlled, trial of home-administered rhythmic 10-Hz median nerve stimulation for the reduction of tics, and suppression of the urge-to-tic, in individuals with Tourette syndrome and chronic tic disorder.
    Maiquez BM; Smith C; Dyke K; Chou CP; Kasbia B; McCready C; Wright H; Jackson JK; Farr I; Badinger E; Jackson GM; Jackson SR
    J Neuropsychol; 2023 Sep; 17(3):540-563. PubMed ID: 37133932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS study.
    Lasch F; Guizzaro L; Aguirre Dávila L; Müller-Vahl K; Koch A
    Pharm Stat; 2021 May; 20(3):675-691. PubMed ID: 33594741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life events and Tourette syndrome.
    Steinberg T; Shmuel-Baruch S; Horesh N; Apter A
    Compr Psychiatry; 2013 Jul; 54(5):467-73. PubMed ID: 23219489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-esteem in adults with Tourette syndrome and chronic tic disorders: The roles of tic severity, treatment, and comorbidity.
    Weingarden H; Scahill L; Hoeppner S; Peterson AL; Woods DW; Walkup JT; Piacentini J; Wilhelm S
    Compr Psychiatry; 2018 Jul; 84():95-100. PubMed ID: 29729555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tic Reduction in Adult Onset Gilles De La Tourette Syndrome Using as Required Nabiximols Spray.
    Schwittay MA; Steinbrecher A; Lobsien E
    Tremor Other Hyperkinet Mov (N Y); 2021; 11():33. PubMed ID: 34430070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Glutamate Modulators in Tic Suppression: A Double-Blind, Randomized Control Trial of D-serine and Riluzole in Tourette Syndrome.
    Lemmon ME; Grados M; Kline T; Thompson CB; Ali SF; Singer HS
    Pediatr Neurol; 2015 Jun; 52(6):629-34. PubMed ID: 26002052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
    Osland ST; Steeves TD; Pringsheim T
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007990. PubMed ID: 29944175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.
    Coffey B; Jankovic J; Claassen DO; Jimenez-Shahed J; Gertz BJ; Garofalo EA; Stamler DA; Wieman M; Savola JM; Gordon MF; Alexander JK; Barkay H; Harary E
    JAMA Netw Open; 2021 Oct; 4(10):e2129397. PubMed ID: 34661664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of serum ferritin level and tic severity in children with Tourette syndrome.
    Ghosh D; Burkman E
    Childs Nerv Syst; 2017 Aug; 33(8):1373-1378. PubMed ID: 28470381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome.
    Abi-Jaoude E; Bhikram T; Parveen F; Levenbach J; Lafreniere-Roula M; Sandor P
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):835-845. PubMed ID: 36040329
    [No Abstract]   [Full Text] [Related]  

  • 18. Mindfulness-based stress reduction for Tourette Syndrome and Chronic Tic Disorder: a pilot study.
    Reese HE; Vallejo Z; Rasmussen J; Crowe K; Rosenfield E; Wilhelm S
    J Psychosom Res; 2015 Mar; 78(3):293-8. PubMed ID: 25149879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study.
    Hoekstra PJ; Minderaa RB; Kallenberg CG
    J Clin Psychiatry; 2004 Apr; 65(4):537-42. PubMed ID: 15119917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecopipam for Tourette Syndrome: A Randomized Trial.
    Gilbert DL; Dubow JS; Cunniff TM; Wanaski SP; Atkinson SD; Mahableshwarkar AR
    Pediatrics; 2023 Feb; 151(2):. PubMed ID: 36628546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.